WO2008035816A1 - Promoteur de régénération des tissus durs - Google Patents
Promoteur de régénération des tissus durs Download PDFInfo
- Publication number
- WO2008035816A1 WO2008035816A1 PCT/JP2007/069118 JP2007069118W WO2008035816A1 WO 2008035816 A1 WO2008035816 A1 WO 2008035816A1 JP 2007069118 W JP2007069118 W JP 2007069118W WO 2008035816 A1 WO2008035816 A1 WO 2008035816A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bone
- diatomaceous earth
- hard tissue
- regeneration
- administered
- Prior art date
Links
- 230000017423 tissue regeneration Effects 0.000 title claims abstract description 13
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 80
- 239000005909 Kieselgur Substances 0.000 claims abstract description 70
- 235000013305 food Nutrition 0.000 claims abstract description 28
- 239000000203 mixture Substances 0.000 claims abstract description 15
- 210000000988 bone and bone Anatomy 0.000 claims description 95
- 210000001519 tissue Anatomy 0.000 claims description 33
- 210000001185 bone marrow Anatomy 0.000 claims description 28
- 239000008194 pharmaceutical composition Substances 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 11
- 239000004480 active ingredient Substances 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 241001465754 Metazoa Species 0.000 claims description 7
- 210000004268 dentin Anatomy 0.000 claims description 7
- 230000002950 deficient Effects 0.000 abstract description 40
- 238000011069 regeneration method Methods 0.000 abstract description 20
- 230000008929 regeneration Effects 0.000 abstract description 19
- 239000003814 drug Substances 0.000 abstract description 13
- 229940079593 drug Drugs 0.000 abstract description 13
- 230000001172 regenerating effect Effects 0.000 abstract description 3
- 230000001771 impaired effect Effects 0.000 abstract 3
- 230000001054 cortical effect Effects 0.000 description 22
- 208000006735 Periostitis Diseases 0.000 description 15
- 210000003460 periosteum Anatomy 0.000 description 15
- 230000010478 bone regeneration Effects 0.000 description 11
- 230000007547 defect Effects 0.000 description 11
- 238000001356 surgical procedure Methods 0.000 description 10
- 206010052428 Wound Diseases 0.000 description 9
- 208000027418 Wounds and injury Diseases 0.000 description 9
- 238000000605 extraction Methods 0.000 description 9
- 229910052500 inorganic mineral Inorganic materials 0.000 description 9
- 239000011707 mineral Substances 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- 210000003141 lower extremity Anatomy 0.000 description 7
- 238000003384 imaging method Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- -1 pH adjusters Substances 0.000 description 6
- 241000700159 Rattus Species 0.000 description 4
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000009877 rendering Methods 0.000 description 4
- 229910052710 silicon Inorganic materials 0.000 description 4
- 239000010703 silicon Substances 0.000 description 4
- 230000008719 thickening Effects 0.000 description 4
- 235000010724 Wisteria floribunda Nutrition 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 230000033558 biomineral tissue development Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000037182 bone density Effects 0.000 description 3
- 230000002308 calcification Effects 0.000 description 3
- 230000003073 embolic effect Effects 0.000 description 3
- 239000013505 freshwater Substances 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000007943 implant Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000004445 quantitative analysis Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 231100000699 Bacterial toxin Toxicity 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 235000011941 Tilia x europaea Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 239000000688 bacterial toxin Substances 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000010894 electron beam technology Methods 0.000 description 2
- 238000004453 electron probe microanalysis Methods 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 210000002758 humerus Anatomy 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000004571 lime Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 230000003239 periodontal effect Effects 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 210000002303 tibia Anatomy 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000206761 Bacillariophyta Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000725101 Clea Species 0.000 description 1
- 241000243321 Cnidaria Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000206745 Nitzschia alba Species 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- 239000011398 Portland cement Substances 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000002583 angiography Methods 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000001511 capsicum annuum Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 239000004053 dental implant Substances 0.000 description 1
- 210000004262 dental pulp cavity Anatomy 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- HMOQEAOCAPKHRP-JDYVBSGKSA-L disodium (2R)-2-[(1S)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2H-furan-4-olate hydrogen sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HMOQEAOCAPKHRP-JDYVBSGKSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 230000002188 osteogenic effect Effects 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 210000002379 periodontal ligament Anatomy 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000002601 radiography Methods 0.000 description 1
- 210000000614 rib Anatomy 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000005368 silicate glass Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 210000000623 ulna Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/24—Compounds of alkaline earth metals, e.g. magnesium
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/015—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/29—Mineral substances, e.g. mineral oils or clays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3637—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the origin of the biological material other than human or animal, e.g. plant extracts, algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/428—Vitamins, e.g. tocopherol, riboflavin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Inorganic Chemistry (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Husbandry (AREA)
- Botany (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Transplantation (AREA)
- Molecular Biology (AREA)
- Alternative & Traditional Medicine (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008535422A JP5557448B2 (ja) | 2006-09-21 | 2007-09-21 | 硬組織再生促進剤 |
US12/441,788 US20100143488A1 (en) | 2006-09-21 | 2007-09-21 | Promoter of hard tissue regeneration |
CN200780040020XA CN101573127B (zh) | 2006-09-21 | 2007-09-21 | 硬组织再生促进剂 |
EP07828859A EP2070541A4 (en) | 2006-09-21 | 2007-09-21 | MEANS FOR PROMOTING REGENERATION OF HARD FABRIC |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006-256374 | 2006-09-21 | ||
JP2006256374 | 2006-09-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008035816A1 true WO2008035816A1 (fr) | 2008-03-27 |
Family
ID=39200632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2007/069118 WO2008035816A1 (fr) | 2006-09-21 | 2007-09-21 | Promoteur de régénération des tissus durs |
Country Status (6)
Country | Link |
---|---|
US (1) | US20100143488A1 (ja) |
EP (1) | EP2070541A4 (ja) |
JP (2) | JP5557448B2 (ja) |
KR (1) | KR20090098783A (ja) |
CN (1) | CN101573127B (ja) |
WO (1) | WO2008035816A1 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100143488A1 (en) * | 2006-09-21 | 2010-06-10 | Toshiki Oguro | Promoter of hard tissue regeneration |
KR101638373B1 (ko) * | 2014-09-16 | 2016-07-12 | 주식회사 마루치 | 초속경 수경성 바인더 조성물 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3271161A (en) * | 1964-06-22 | 1966-09-06 | John C Eshleman | Poultry feed containing about 1% diatomaceous earth |
JPS5126211A (en) * | 1974-08-24 | 1976-03-04 | Masakuni Kanai | Honeno seiseisokushinzaino seizohoho |
JPH01228432A (ja) * | 1988-03-07 | 1989-09-12 | Control Feeds Inc | 動物及び鳥類の飼料添加物及びその製造方法 |
JPH03136664A (ja) | 1989-04-20 | 1991-06-11 | Fbfc Internatl Sa:Nv | 骨組織で充填することによる骨欠陥部または欠損部の修復方法 |
JPH05260905A (ja) * | 1992-01-20 | 1993-10-12 | Pfizer Pharmaceut Co Ltd | 家畜用飼料添加物およびそれを用いた家畜用飼料 |
JPH09505305A (ja) * | 1993-11-16 | 1997-05-27 | インターメディクス オーソピーディクス/デンバー,インコーポレイテッド | 骨形成促進生成物および骨形成方法 |
US5769638A (en) | 1993-04-23 | 1998-06-23 | Loma Linda University | Tooth filling material and method of use |
JP2003289829A (ja) * | 2002-04-04 | 2003-10-14 | Takatsugu Kakeida | 栄養補助食品 |
JP2004137202A (ja) * | 2002-10-18 | 2004-05-13 | Yoshio Watanabe | 花粉症に対する免疫性向上クリ−ム |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3316726A1 (de) * | 1983-05-07 | 1984-11-08 | Rex Ellis Preston Victoria Newnham | Therapeutisch wirksames gemisch |
US4729902A (en) * | 1983-08-11 | 1988-03-08 | Control Feeds, Inc. | Animal and fowl feed supplement and process of manufacture |
JPS6172671A (ja) * | 1984-09-18 | 1986-04-14 | 村井 吉雄 | セラミツクスの組成とその使用方法 |
JPS6291447A (ja) * | 1985-10-17 | 1987-04-25 | 昭和薬品化工株式会社 | セメント組成物 |
FI81010C (fi) * | 1986-09-05 | 1990-09-10 | Biocon Oy | Stoedstruktur foer bentransplantat. |
US4954448A (en) * | 1988-12-27 | 1990-09-04 | Nelson Research & Development Company | Modulation of adenylate cyclase response |
DE69214005T2 (de) * | 1991-05-01 | 1997-05-15 | Chichibu Onoda Cement Corp | Erhärtende Zusammensetzungen zur Verwendung in der Medizin oder Zahnheilkunde |
JP2002504083A (ja) * | 1996-03-05 | 2002-02-05 | オーケスト インコーポレイテッド | ヒアルロン酸および増殖因子による骨の増殖を促進する方法 |
US5707970A (en) * | 1997-02-12 | 1998-01-13 | Nutrition 21 | Arginine silicate complex and use thereof |
WO2000059460A1 (en) * | 1999-04-07 | 2000-10-12 | W.R. Grace & Co.-Conn. | Additives for desensitizing and remineralizing dentifrice compositions |
ES2162746B1 (es) * | 1999-10-21 | 2003-02-16 | Lipotec Sa | Microcapsulas para la estabilizacion de productos cosmeticos, farmaceuticos o de alimentacion. |
GB2363115A (en) * | 2000-06-10 | 2001-12-12 | Secr Defence | Porous or polycrystalline silicon orthopaedic implants |
JP2002220314A (ja) * | 2000-11-21 | 2002-08-09 | Gc Corp | 根管充填用グラスアイオノマー系シーラー用粉末 |
JP2005052065A (ja) * | 2003-08-04 | 2005-03-03 | Nof Corp | 栄養組成物 |
US8895540B2 (en) * | 2003-11-26 | 2014-11-25 | DePuy Synthes Products, LLC | Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor |
US20050123490A1 (en) * | 2003-12-04 | 2005-06-09 | Kazue Yamagishi | Composition and method for prevention and treatment of dental caries |
CN100439366C (zh) * | 2003-12-16 | 2008-12-03 | 辉瑞产品公司 | 作为PDE2抑制剂的吡啶并[2,3-d]嘧啶-2,4-二胺 |
JP2005253442A (ja) * | 2004-03-09 | 2005-09-22 | Hitachi Medical Corp | 発現プロファイルが人間の歯髄幹細胞と間葉幹細胞の間で異なる遺伝子のグループ |
JP4588403B2 (ja) * | 2004-10-04 | 2010-12-01 | 森永乳業株式会社 | カルシウム・マグネシウム含有組成物の製造方法 |
GB0504657D0 (en) * | 2005-03-05 | 2005-04-13 | Psimedica Ltd | Compositions and methods of treatment |
WO2006110393A1 (en) * | 2005-04-04 | 2006-10-19 | The Regents Of The University Of California | Inorganic materials for hemostatic modulation and therapeutic wound healing |
US20100143488A1 (en) * | 2006-09-21 | 2010-06-10 | Toshiki Oguro | Promoter of hard tissue regeneration |
-
2007
- 2007-09-21 US US12/441,788 patent/US20100143488A1/en not_active Abandoned
- 2007-09-21 EP EP07828859A patent/EP2070541A4/en not_active Withdrawn
- 2007-09-21 KR KR1020097008045A patent/KR20090098783A/ko not_active Application Discontinuation
- 2007-09-21 CN CN200780040020XA patent/CN101573127B/zh not_active Expired - Fee Related
- 2007-09-21 JP JP2008535422A patent/JP5557448B2/ja not_active Expired - Fee Related
- 2007-09-21 WO PCT/JP2007/069118 patent/WO2008035816A1/ja active Application Filing
-
2012
- 2012-01-13 JP JP2012005534A patent/JP5898500B2/ja not_active Expired - Fee Related
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3271161A (en) * | 1964-06-22 | 1966-09-06 | John C Eshleman | Poultry feed containing about 1% diatomaceous earth |
JPS5126211A (en) * | 1974-08-24 | 1976-03-04 | Masakuni Kanai | Honeno seiseisokushinzaino seizohoho |
JPH01228432A (ja) * | 1988-03-07 | 1989-09-12 | Control Feeds Inc | 動物及び鳥類の飼料添加物及びその製造方法 |
JPH03136664A (ja) | 1989-04-20 | 1991-06-11 | Fbfc Internatl Sa:Nv | 骨組織で充填することによる骨欠陥部または欠損部の修復方法 |
JPH05260905A (ja) * | 1992-01-20 | 1993-10-12 | Pfizer Pharmaceut Co Ltd | 家畜用飼料添加物およびそれを用いた家畜用飼料 |
US5769638A (en) | 1993-04-23 | 1998-06-23 | Loma Linda University | Tooth filling material and method of use |
JPH09505305A (ja) * | 1993-11-16 | 1997-05-27 | インターメディクス オーソピーディクス/デンバー,インコーポレイテッド | 骨形成促進生成物および骨形成方法 |
JP2003289829A (ja) * | 2002-04-04 | 2003-10-14 | Takatsugu Kakeida | 栄養補助食品 |
JP2004137202A (ja) * | 2002-10-18 | 2004-05-13 | Yoshio Watanabe | 花粉症に対する免疫性向上クリ−ム |
Non-Patent Citations (3)
Title |
---|
IINUMA Y. ET AL.: "Kayosei Keisei Kagobutsu to sono Tennen Sozai no Hone Bunka Seijuku Kanren Idenshi Hatsugen eno Eikyo", THE JAPANSE JOURNAL OF CLINICAL PATHOLOGY, DAI 51 KAI JAPANESE SOCIETY OF LABORATORY MEDICINE SOKAI (DAI 51 KAI JAPANESE SOCIETY OF LABORATORY MEDICINE SOKAI . DAI 44 KAI JAPAN SOCIETY OF CLINICAL CHEMISTRY NENKAI RENGO TAIKAI), vol. 52, no. SUPPL. 1, 31 July 2004 (2004-07-31), pages 137 + ABSTR. NO. O-107, XP003021860 * |
MAEHIRA F. ET AL.: "Kayosei Keiso Kagobutsu no Hone Seibun, Hone Kyodo, Hone Bunka Seijuku Kanren Idenshi Hatsugen eno Eikyo", THE JAPANESE SOCIETY FOR BONE AND MINERAL RESEARCH GAKUJUTSU SHUKAI PROGRAM SHOROKUSHU, DAI 23 KAI, vol. 23, 20 June 2005 (2005-06-20), pages 255 + ABSTR. NO. P2-01, XP003021859 * |
See also references of EP2070541A4 |
Also Published As
Publication number | Publication date |
---|---|
KR20090098783A (ko) | 2009-09-17 |
CN101573127B (zh) | 2013-04-10 |
JP5557448B2 (ja) | 2014-07-23 |
JP5898500B2 (ja) | 2016-04-06 |
EP2070541A1 (en) | 2009-06-17 |
JPWO2008035816A1 (ja) | 2010-01-28 |
US20100143488A1 (en) | 2010-06-10 |
JP2012116844A (ja) | 2012-06-21 |
CN101573127A (zh) | 2009-11-04 |
EP2070541A4 (en) | 2011-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Utneja et al. | Current perspectives of bio-ceramic technology in endodontics: calcium enriched mixture cement-review of its composition, properties and applications | |
Wagner | Clinical and histological case study using resorbable hydroxylapatite for the repair of osseous defects prior to endosseous implant surgery | |
Clauder et al. | Repair of perforations with MTA: clinical applications and mechanisms of action | |
Leventis et al. | Minimally invasive alveolar ridge preservation utilizing an in situ hardening β-tricalcium phosphate bone substitute: a multicenter case series | |
Goel et al. | Management of dens invaginatus type II associated with immature apex and large periradicular lesion using platelet-rich fibrin and biodentine | |
Jansisyanont et al. | The effect of acemannan sponges in post-extraction socket healing: A randomized trial | |
Daif | Effect of a multiporous beta–tricalicum phosphate on bone density around dental implants inserted into fresh extraction sockets | |
Clauder | Present status and future directions–Managing perforations | |
Kanda et al. | Implantation of octacalcium phosphate collagen composites (OCP/Col) after extraction of canine deciduous teeth achieved undisturbed permanent tooth eruption | |
de Moraes | Closure of oroantral communication with buccal fat pad flap in zygomatic implant surgery: a case report. | |
Horowitz et al. | Enhancing extraction socket therapy with a biphasic calcium sulfate | |
JP5898500B2 (ja) | 硬組織再生促進剤 | |
Pripatnanont et al. | Dimensional Change and Microstructure of Intraoral Bone Block Grafts Covered with Platelet-Rich Fibrin and a Barrier Membrane in Ridge Augmentation: A Pilot Investigation. | |
Barone et al. | Bone, biomaterials & beyond | |
Lundgren et al. | An experimental rabbit model for jaw-bone healing | |
Arunjaroensuk et al. | Stability of guided bone regeneration with two ratios of biphasic calcium phosphate at implant sites in the esthetic zone: A randomized controlled clinical trial | |
de Almeida Ferreira et al. | Grafting the nasal cavity with 100% anorganic bovine bone: a clinical and histomorphometric pilot report. | |
Corrêa et al. | Myiasis in Elderly Involving Oral and Nasal Cavities—Diagnosis and Treatment | |
Katzap et al. | Utilization of Biphasic Calcium Sulfate as Socket Preservation Grafting as a Prelude to Implant Placement: A Case Report | |
Dudek et al. | Treatment of a mandibular cyst with synthetic bone graft substitute | |
Taman et al. | Post-extraction socket preservation with autogenous bone graft and hyaluronic acid followed by delayed implant placement | |
de Souza Batista et al. | Immediate dental implant placement after removal of complex odontoma | |
Mendes et al. | Anxiety and depression during expecting time for oral cancer treatment | |
Clauder | Repair of Pulp Chamber and Root Perforations | |
de Vasconcellos et al. | Massive ameloblastic fibroma treated with surgical conservative treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200780040020.X Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07828859 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008535422 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020097008045 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007828859 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12441788 Country of ref document: US |